By Associate Professor Min Jun

Journal articles

Ha J; Gallagher MP; Jun M, 2021, 'The Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category', Journal of the American Society of Nephrology, 32, pp. 728 - 728, http://dx.doi.org/10.1681/asn.20213210s1728c

Kim H; Wang D; Chalmers J; Jun M; Zoungas S; Marre M; Hamet P; Harrap S; Mancia G; Poulter NR; Cooper ME; Woodward M; Selvin E; Rebholz CM, 2020, 'Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial', Journal of Diabetes, 12, pp. 929 - 941, http://dx.doi.org/10.1111/1753-0407.13083

Zhang H; Rogers K; Sukkar L; Jun M; Kang A; Young T; Campain A; Cass A; Chow CK; Comino E; Foote C; Gallagher M; Knight J; Liu B; Lung T; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Jardine M; Hockham C, 2020, 'Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data', Journal of Clinical and Translational Endocrinology, 22, pp. 100240, http://dx.doi.org/10.1016/j.jcte.2020.100240

Pettigrew S; Jun M; Roberts I; Bullen C; Nallaiah K; Rodgers A, 2020, 'Preferences for tobacco cessation information and support during Covid-19', Journal of Addiction Medicine, 14, pp. E362 - E365, http://dx.doi.org/10.1097/ADM.0000000000000743

Xie Y; Baker J; Young T; Jun M; Sukkar L; Campain A; Kang A; Cass A; Hu J; Peiris D; Pollock C; Wong G; Zoungas S; Rogers K; Jardine M; Hockham C, 2020, 'Therapy escalation following an elevated hba1c in adults aged 45 years and older living with diabetes in Australia: A real-world observational analysis', Diabetes Care, 43, pp. e185 - e187, http://dx.doi.org/10.2337/dc20-0269

Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A, 2020, 'Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study', CMAJ open, 8, pp. E877 - E886, http://dx.doi.org/10.9778/cmajo.20200055

Ohkuma T; Peters SAE; Jun M; Harrap S; Cooper M; Hamet P; Poulter N; Chalmers J; Woodward M, 2020, 'Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study', Diabetes, Obesity and Metabolism, 22, pp. 1818 - 1826, http://dx.doi.org/10.1111/dom.14103

Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2020, 'Haemodialysis duration, frequency and intensity for end-stage kidney disease', Cochrane Database of Systematic Reviews, 2020, http://dx.doi.org/10.1002/14651858.CD010064.pub2

Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM, 2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446

Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S, 2020, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2020, pp. cd009966, http://dx.doi.org/10.1002/14651858.CD009966.pub3

Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M, 2020, 'Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials', Clinical Journal of the American Society of Nephrology, 15, pp. 1129 - 1138, http://dx.doi.org/10.2215/CJN.12201019

Harris K; Oshima M; Sattar N; Würtz P; Jun M; Welsh P; Hamet P; Harrap S; Poulter N; Chalmers J; Woodward M, 2020, 'Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study', Diabetologia, 63, pp. 1637 - 1647, http://dx.doi.org/10.1007/s00125-020-05162-z

Weaver RG; James MT; Ravani P; Weaver CG; Lamb EJ; Tonelli M; Manns BJ; Quinn RR; Jun M; Hemmelgarn BR, 2020, 'Erratum: Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: Development of equations using same-DayMeasurements (Journal of the American Society of Nephrology (2020) 31 (591-601) DOI: 10.1681/ASN.2019060605)', Journal of the American Society of Nephrology, 31, pp. 1140, http://dx.doi.org/10.1681/ASN.2020030291

Sukkar L; Kang A; Hockham C; Young T; Jun M; Foote C; Pecoits-Filho R; Neuen B; Rogers K; Pollock C; Cass A; Sullivan D; Wong G; Knight J; Peiris D; Gallagher M; Jardine M, 2020, 'Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study', Diabetes Care, 43, pp. 982 - 990, http://dx.doi.org/10.2337/dc19-1803

Foote C; Hockham C; Sukkar L; Campain A; Kang A; Young T; Cass A; Chow CK; Comino E; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Rogers K; Jun M; Jardine M; Harris M, 2020, 'Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646

Foote C; Hockham C; Sukkar L; Campain A; Kang A; Young T; Cass A; Chow CK; Comino E; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Rogers K; Jun M; Jardine M, 2020, 'Examining outcomes in chronic disease in the 45 and up study (the EXTEnD45 study): Protocol for an Australian linked cohort study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646

Weaver RG; James MT; Ravani P; Weaver CGW; Lamb EJ; Tonelli M; Manns BJ; Quinn RR; Jun M; Hemmelgarn BR, 2020, 'Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: Development of Equations using Same-Day Measurements', Journal of the American Society of Nephrology, 31, pp. 591 - 601, http://dx.doi.org/10.1681/ASN.2019060605

Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S, 2020, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.cd009956.pub3

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group , 2020, 'KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.', Kidney Int, 98, pp. S1 - S115, http://dx.doi.org/10.1016/j.kint.2020.06.019

Hockham C; Bao L; Tiku A; Badve S; Gallagher MP; Jardine MJ; Jha V; Woodward M; Jun M, 2020, 'Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 31, pp. 179 - 179, http://dx.doi.org/10.1681/asn.20203110s1179c

Liyanage T; Toyama T; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Seong HL; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2020, 'SUN-107 THE PREVALENCE OF CHRONIC KIDNEY DISEASE IN ASIA – A SYSTEMATIC REVIEW AND ANALYSIS', Kidney International Reports, 5, pp. S245 - S245, http://dx.doi.org/10.1016/j.ekir.2020.02.634

OSHIMA M; Wong MG; Hara A; Toyama T; Jun M; Jardine M; Pollock C; Woodward M; Chalmers J; Perkovic V; Wada T, 2020, 'SUN-161 CIRCULATING AUTOANTIBODIES TO ERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES', Kidney International Reports, 5, pp. S267 - S267, http://dx.doi.org/10.1016/j.ekir.2020.02.690

Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V, 2019, 'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study', Diabetologia, 62, pp. 1988 - 1997, http://dx.doi.org/10.1007/s00125-019-4948-4

Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M, 2019, 'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrology, 24, pp. 1056 - 1063, http://dx.doi.org/10.1111/nep.13530

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M, 2019, 'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrology, 14, pp. 862 - 872, http://dx.doi.org/10.2215/CJN.13391118

Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648

Ha JT; Badve SV; Jun M, 2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/MNH.0000000000000493

Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M, 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONE, 14, pp. e0213192, http://dx.doi.org/10.1371/journal.pone.0213192

Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060

Harrison TG; Tam-Tham H; Hemmelgarn BR; Elliott M; James MT; Ronksley PE; Jun M, 2019, 'Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis', Canadian Journal of Cardiology, 35, pp. 77 - 91, http://dx.doi.org/10.1016/j.cjca.2018.10.014

Turakhia MP; Blankestijn PJ; Carrero JJ; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C; Amann K; Banerjee D; Bansal N; Boriani G; Bunch J; Chan CT; Charytan DM; Conen D; Friedman AN; Genovesi S; Holden RM; House AA; Jadoul M; Jar-Dine AG; Johnson DW; Jun M; Labriola L; Mark PB; McCullough PA; Nolin TD; Potpara TS; Pun PH; Ribeiro ALP; Rossignol P; Shen JI; Sood MM; Tsukamoto Y; Yee-Moon Wang A; Weir MR; Wetmore JB; Wranicz JK; Yamasaki H, 2019, 'CHRONIC KIDNEY DISEASE AND ARRHYTHMIAS: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE', Nephrology (Saint-Petersburg), 23, pp. 18 - 40, http://dx.doi.org/10.24884/1561-6274-2019-23-2-18-40

Ohkuma T; Zoungas S; Jun M; Lisheng L; Mancia G; Marre M; Rodgers A; Williams B; Woodward M; Chalmers J, 2019, 'Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial', Diabetes, Obesity and Metabolism, 22, pp. 452 - 457, http://dx.doi.org/10.1111/dom.13878

Sukkar L; Talbot B; Jun M; Dempsey E; Walker R; Hooi L; Cass A; Jardine M; Gallagher M, 2019, 'Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort', Canadian Journal of Kidney Health and Disease, 6, pp. 2054358119879896, http://dx.doi.org/10.1177/2054358119879896

HOCKHAM C; Kang A; Young T; Sukkar L; Jun M; Rogers K; Baker J; Cass A; Jardine M, 2019, 'SAT-241 SMALL AREA-LEVEL VARIATION IN CHRONIC KIDNEY DISEASE PREVALENCE AND INCIDENCE IN NEW SOUTH WALES', Kidney International Reports, 4, pp. S108 - S108, http://dx.doi.org/10.1016/j.ekir.2019.05.277

OSHIMA M; Jun M; Toyama T; Perkovic V; Chalmers J; Woodward M, 2019, 'SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES', Kidney International Reports, 4, pp. S128 - S128, http://dx.doi.org/10.1016/j.ekir.2019.05.325

YOUNG T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-288 Trends in pharmacotherapy for diabetes in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S128 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.326

Young T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-289 Association between the intensity of diabetes pharmacotherapy regimens, persistence and achieved HbA1c in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S129 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.327

JUN M; Ohkuma T; Woodward M; Chalmers J; Zoungas S, 2019, 'SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS', Kidney International Reports, 4, pp. S131 - S131, http://dx.doi.org/10.1016/j.ekir.2019.05.334

Toyama T; NEUEN B; Jun M; Ohkuma T; Neal B; Jardine M; Heerspink H; Ninomiya T; Wada T; Perkovic V, 2019, 'SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. s133, http://dx.doi.org/10.1016/j.ekir.2019.05.338

TALBOT B; Lin R; Sagar P; Sen S; Jun M; Gallagher M, 2019, 'SUN-057 Reducing Central Venous Catheter Burden in Haemodialysis Patients: The Impact of Changing Practice within an Australian Renal Unit', Kidney International Reports, 4, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2019.05.453

TALBOT B; Sagar P; Lin R; Jun M; Sen S; Gallagher M, 2019, 'SUN-178 The Impact of Acute Kidney Injury Requiring Haemodialysis on Patient Survival: 10 Years of Prospective Data', Kidney International Reports, 4, pp. S232 - S232, http://dx.doi.org/10.1016/j.ekir.2019.05.580

Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2

Peng T; Zhuo L; Wang Y; Jun M; Li G; Wang L; Hong D, 2018, 'Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients', Nephrology, 23, pp. 669 - 675, http://dx.doi.org/10.1111/nep.13081

Turakhia MP; Blankestijn PJ; Carrero J-J; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C, 2018, 'Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', EUROPEAN HEART JOURNAL, 39, pp. 2314 - +, http://dx.doi.org/10.1093/eurheartj/ehy060

Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE; Tamura MK; Tonelli MA; Wheeler DC; Winkelmayer WC; Cheung M; Hemmelgarn BR; Abu-Alfa AK; Anand S; Arici M; Ballew SH; Block GA; Burgos-Calderon R; Charytan DM; Das-Gupta Z; Dwyer JP; Fliser D; Froissart M; Gill JS; Griffith KE; Harris DC; Huffman K; Inker LA; Jager KJ; Jun M; Kalantar-Zadeh K; Kasiske BL; Kovesdy CP; Krane V; Lamb EJ; Lerma EV; Levey AS; Levin A; Julián Mauro JC; Nash DM; Navaneethan SD; O'Donoghue D; Obrador GT; Pecoits-Filho R; Robinson BM; Schäffner E; Segev DL; Stengel B; Stenvinkel P; Tangri N; Tentori F; Tsukamoto Y; Turakhia MP; Vazquez MA; Yee-Moon Wang A; Williams AW, 2018, 'Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, 93, pp. 1281 - 1292, http://dx.doi.org/10.1016/j.kint.2018.02.006

Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M, 2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, 41, pp. 163 - 170, http://dx.doi.org/10.2337/dc17-1467

Galbraith L; Jacobs C; Hemmelgarn BR; Donald M; Manns BJ; Jun M, 2018, 'Chronic disease management interventions for people with chronic kidney disease in primary care: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 33, pp. 112 - 121, http://dx.doi.org/10.1093/ndt/gfw359

Jun M; Lix LM; Durand M; Dahl M; Paterson JM; Dormuth CR; Ernst P; Yao S; Renoux C; Tamim H; Wu C; Mahmud SM; Hemmelgarn BR, 2017, 'Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study', BMJ, 359, http://dx.doi.org/10.1136/bmj.j4323

Ohkuma T; Jun M; Woodward M; Zoungas S; Cooper ME; Grobbee DE; Hamet P; Mancia G; Williams B; Welsh P; Sattar N; Shaw JE; Rahimi K; Chalmers J, 2017, 'Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trial', Diabetes Care, 40, pp. 1203 - 1209, http://dx.doi.org/10.2337/dc17-0509

Back to profile page